Skip to main content
OpenTrials
Completed

NCT Number: NCT07771946

Audio-Described Menopause Education Program in Visually Impaired Women

This randomized controlled trial was conducted to evaluate the effect of an audio-described menopause education program on menopause knowledge and menopausal symptoms in women with visual impairment. A total of 46 women who were members of the Ankara Branch of the Altı Nokta Blind Association were randomly assigned to either an intervention group (n=23) or a control group (n=23). The intervention group received an accessible menopause education program, while the control group did not receive the intervention during the study period. Outcomes included menopause knowledge and menopausal symptom severity, assessed using standardized measurement tools.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Menopause Blindness Eye Diseases Menopausal Symptoms Nervous System Diseases Neurologic Manifestations Pathological Conditions, Signs and Symptoms Sensation Disorders Signs and Symptoms Vision Disorders Visual Impairment and Blindness (Excl Colour Blindness) Women's Health Education

Age range

40 year–60 year

Sex eligibility

Female

Study type

Interventional

Phase

Not applicable

Primary location

Ankara University

Ankara, Altindağ, 06250, Turkey (Türkiye)

About this study

This study was designed as a randomized controlled trial in accordance with CONSORT guidelines. It aimed to determine the effectiveness of an audio-described menopause symptom and awareness education program for women with visual impairment on menopause knowledge and menopausal symptoms.

The study sample consisted of 46 women who were members of the Ankara Branch of the Altı Nokta Blind Association. Participants were randomly allocated in a 1:1 ratio to either the intervention group (n=23) or the control group (n=23).

Data were collected using a demographic information form, the Menopause Knowledge Scale, and the Menopause Rating Scale. The intervention group received an audio-described educational program designed to improve accessibility for women with visual impairment, while the control group did not receive the intervention during the study period.

Statistical analyses included descriptive statistics, Fisher-Freeman-Halton Exact test, Pearson chi-square test, Cronbach's alpha reliability analysis, assessment of skewness and kurtosis for normality, Pearson correlation analysis, independent samples t-test, and analysis of covariance (ANCOVA). Statistical significance was set at p < 0.05.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Being a member of the Ankara Branch of the Altı Nokta Blind Association,
  • Being a woman with visual impairment (congenital or acquired),
  • Being female,
  • Being between 40 and 60 years of age,
  • Being able to speak Turkish,
  • Having no additional communication problems other than visual impairment,
  • Having experienced at least 12 months of amenorrhea (STRAW+1 criteria).

Exclusion criteria

  • Refusal to participate in the study,
  • Previous participation in a structured menopause-related education program,
  • Use of pharmacological treatment for the management of menopausal symptoms,
  • Use of non-pharmacological methods for menopausal symptom management (e.g., yoga, aromatherapy, phytotherapy, etc.),
  • Surgical menopause,
  • Having additional disabilities other than visual impairment (hearing, intellectual, or physical disabilities).

Withdrawal / Discontinuation Criteria

  • Initiation of any pharmacological or non-pharmacological intervention aimed at reducing menopausal symptoms during the study period,
  • Non-adherence to the study protocol,
  • Voluntary withdrawal from the study.

Treatment and study plan

Audio-Described Menopause Education Program

Behavioral

This intervention consisted of a structured audio-described menopause education program developed for women with visual impairment. The program provided accessible information about menopause, menopausal symptoms, and symptom management strategies to improve knowledge and awareness.

Primary outcomes

  1. Menopause Knowledge

    Time frame: Measured at three time points: baseline (pre-test), immediately after the intervention (T1), and 1 month post-intervention (T2).

    To assess changes in menopause knowledge following the audio-described menopause education program. The total score of the "Menopause Knowledge Scale" ranges from 14 to 70, with higher scores indicating a higher level of overall knowledge about menopause. Similarly, higher scores on the General Menopause Knowledge subscale (5-25) and the Knowledge of Menopausal Symptoms and Management subscale (9-45) indicate greater knowledge in the respective domains.

  2. Menopausal Symptom Severity

    Time frame: Measured at three time points: baseline (pre-test), immediately after the intervention (T1), and 1 month post-intervention (T2).

    To evaluate changes in menopausal symptom severity following the audio-described menopause education program. The Menopause Rating Scale was used to assess the severity of menopausal symptoms.The total score of the scale ranges from 0 to 44. Higher total scores indicate greater severity of menopausal symptoms and a more negative impact on quality of life.

Sponsors and collaborators

Lead sponsor

Ankara University

Other

Registry information

Official study title

The Effect of Education Provided Through Audio Description Method on Menopause Knowledge and Menopausal Symptoms in Visually Impaired Women: Randomized Controlled Trial

Important dates

Study start
2025
Primary completion
2025
Study completion
2025
First posted
Aug 19, 2026
Registry last updated
Aug 19, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.